NetworkNewsAudio – A Micro-Cap Biotech Just Cleared a Milestone Most Never Reach
This audio news release has been disseminated on behalf of Quantum BioPharma and may include a paid advertisement. Related Editorial Multiple sclerosis (“MS”) drugs on the market today can slow the disease down, but none of them stop it, and none of them give patients back what they have already lost. Nearly one million people in the United States, and close to 2.9 million worldwide, live with that reality, watching a disease that can gradually erode mobility, vision, and basic bodily control. That gap has just gotten a serious new challenger. Quantum BioPharma Ltd. (NASDAQ: QNTM) (Profile) has received FDA clearance…







